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Urothelium muscarinic activation 
phosphorylates CBSSer227 via  
cGMP/PKG pathway causing  
human bladder relaxation  
through H2S production
Roberta d’Emmanuele di Villa Bianca1,2,*, Emma Mitidieri1,*, Ferdinando Fusco2,3, 
Annapina Russo1, Valentina Pagliara1, Teresa Tramontano1, Erminia Donnarumma1, 
Vincenzo Mirone2,3, Giuseppe Cirino1,2, Giulia Russo1 & Raffaella Sorrentino1,2
The urothelium modulates detrusor activity through releasing factors whose nature has not been clearly 
defined. Here we have investigated the involvement of H2S as possible mediator released downstream 
following muscarinic (M) activation, by using human bladder and urothelial T24 cell line. Carbachol 
stimulation enhances H2S production and in turn cGMP in human urothelium or in T24 cells. This 
effect is reversed by cysthationine-β-synthase (CBS) inhibition. The blockade of M1 and M3 receptors 
reverses the increase in H2S production in human urothelium. In T24 cells, the blockade of M1 receptor 
significantly reduces carbachol-induced H2S production. In the functional studies, the urothelium 
removal from human bladder strips leads to an increase in carbachol-induced contraction that is 
mimicked by CBS inhibition. Instead, the CSE blockade does not significantly affect carbachol-induced 
contraction. The increase in H2S production and in turn of cGMP is driven by CBS-cGMP/PKG-dependent 
phosphorylation at Ser227 following carbachol stimulation. The finding of the presence of this crosstalk 
between the cGMP/PKG and H2S pathway downstream to the M1/M3 receptor in the human urothelium 
further implies a key role for H2S in bladder physiopathology. Thus, the modulation of the H2S pathway 
can represent a feasible therapeutic target to develop drugs for bladder disorders.
The urinary bladder has two important functions, the storage of urine and emptying. Storage of urine occurs at 
low pressure, which implies that the bladder relaxes during the filling phase as opposite to the emptying phase. 
The wall of the bladder, is composed of three layers i) the outer layer, or detrusor muscle, consisting of a mass of 
interlacing smooth muscle fibers and elastic tissue, ii) the middle layer, or lamina propria, a thin layer of areolar 
tissue that connects the muscular with the mucous layer iii) the inner layer, or urothelium, composed of tran-
sitional epithelium. The urothelium in the past was considered as a passive mechanical barrier protecting the 
body from the toxic effects of urine, but in recent years it has been recognized as a functional structure. Actually, 
it is now clearly defined that the urothelium has sensory and secretory functions1–6. One of the most important 
accepted function of the urothelium is to modulate the detrusor activity. Indeed, it is now clear that urothelium 
exerts a significant inhibitory effect on detrusor contractility. What is still matter of debate is the nature of the 
mediator(s) secreted by the urothelium that operate this control. At the present stage it has been hypothesized the 
presence of an urothelium-derived relaxing factor(s), namely UDRF whose nature has not been as yet defined7–10. 
So far it has been suggested, from in vitro studies, that UDRF(s) is released within the urothelium upon muscarin 
(M) receptors stimulation but its chemical nature is still unknown9,10.
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Recently, it has been proposed a new signal molecule in the control of bladder tone i.e. hydrogen sulfide 
(H2S)11. H2S, is the third gaseous transmitter along with nitric oxide (NO) and carbon monoxide, formed by 
L-cysteine mainly through the action of cysthationine-β -synthase (CBS) and cysthationine-γ -lyase (CSE)12–15. It 
is endogenously produced in urinary bladder of trout, mouse, and rat implying that the contribution of this path-
way to bladder function is conserved in different species including human16. Moreover, animal pre-clinical studies 
showed that H2S causes smooth muscle relaxation and/or contraction depending on the species and experi-
mental conditions used17–20. Of note, human functional studies have demonstrated that both sodium hydrogen 
sulfide (NaHS, an H2S donor) or L-cysteine (the H2S precursor) relax human bladder strips11. It has also been 
reported that H2S relaxing effect on human bladder involves potassium-ATP dependent channel activation17. 
Both enzymes CBS and CSE are constitutively expressed either in human urothelium or in detrusor muscle and 
are able to generate H2S11,21. More recently, a key role for CBS in human urothelium has been proposed21. Indeed, 
CBS rather than CSE is the main enzymatic source of H2S biosynthesis in human urothelium. The activity of CBS 
within the urothelium is regulated by phosphorylation. Particularly, the enzyme is shifted to an higher status 
of activity by phoshorylation at Ser227, in a cyclic guanosine monophosphate/protein kinase G (cGMP/PKG)- 
dependent manner21. In other words, an increase in cGMP promotes an enhancement in H2S generation that 
in turn relaxes human bladder. Taken together these findings, H2S appears to be a phylogenetically ancient and 
versatile regulatory molecule involved in the regulation of bladder homeostasis. For this reason, the H2S pathway 
could represent an attractive target for the development of new pharmacological tools. Nevertheless, more stud-
ies are needed in order to clearly define the role of H2S signaling in human bladder pathophysiology. Here, by 
using human urothelium and the urothelial cell line T24, we have investigated i) whether M receptor activation is 
downstream triggered the H2S pathway and ii) if H2S can be considered as an UDRF.
Results
Carbachol-induced contraction is affected by H2S in human bladder strips. The urothelium 
removal significantly potentiates carbachol-induced contraction (1 μ M) (* p < 0.05; Fig. 1A). This finding con-
firms that the urothelium contributes to bladder homeostasis by producing relaxing factors. In order to assess 
the possible involvement of the endogenous H2S in carbachol-induced contraction, human bladder strips with 
urothelium were contracted with carbachol (10 nM–30 μ M) in presence of aminooxyacetc acid (AOAA, 1 mM), a 
CBS inhibitor, DL-propargylglicine (PAG, 10 mM), a CSE inhibitor, or vehicle. AOAA but not PAG significantly 
increases carbachol-induced contraction (* p < 0.05; Fig. 1B). Of note, the effect of AOAA is higher compared 
with PAG treatment (°p < 0.05; Fig. 1B). The vehicle does not affect the concentration-dependent contraction 
induced by carbachol (Fig. 1B).
Carbachol increases H2S production in human urothelium and T24 cells. The incubation with car-
bachol (0.1, 1 and 10 μ M) causes a significant increase in H2S generation compared with vehicle (* * p < 0.01, 
***p < 0.001) in both human urothelium (Fig. 2A) and T24 cells (Fig. 2B). To evaluate the involvement of CBS 
in H2S production induced by carbachol (1 μ M), we have incubated human urothelium as well as T24 cells with 
AOAA (1 mM). CBS inhibition significantly reduces the increase in carbachol-induced H2S production in human 
urothelium (°°°p < 0.001 vs carbachol; Fig. 2C) as well as in T24 cells (°°p < 0.01 vs carbachol; Fig. 2D). In order 
to confirm the CBS role in human urothelium, as previously demonstrated21, we have stably silenced CBS in T24 
cells namely T24Δ CBS (Fig. 2E). T24Δ CBS produces a detectable amount of H2S in basal condition (Fig. 2F). 
When T24Δ CBS cells are stimulated with carbachol (0.1, 1 and 10 μ M) the increased H2S production is blunted 
(Fig. 2F) as compared to control cells (Fig. 2B).
Carbachol phosphorylates CBS through cGMP/PKG pathway. Firstly, we showed the presence of 
eNOS in T24 cells or in human urothelium (Insert in Fig 3A). Since human CBS is activated through cGMP/
PKG-dependent phosphorylation at Ser227,21 we have evaluated whether carbachol increases cGMP in T24 cells. 
Carbachol stimulation (0.1, 1, 10 μ M) significantly increases cGMP levels (* p < 0.05 vs vehicle; Fig 3A). As, 
cGMP/PKG is downstream from the NO signal, we used L-NIO (1 μ M), as eNOS inhibitor, or KT5823 (10 μ M), 
as PKG inhibitor. Both significantly inhibit the increase in H2S production induced by carbachol in T24 cells 
(°°°p < 0.001 vs carbachol; Fig 3B).
Finally, western blot analysis shows that carbachol triggers a significant increase in p-CBS227 compared to 
vehicle (* * p < 0.01 and * * * p < 0.001; Fig 3C,D). The involvement of cGMP/PKG pathway is confirmed by 
the finding that CBS phosphorylation is significantly reduced upon PKG inhibition (°°p < 0.01, °°°p < 0.001 vs 
carbachol; Fig 3C,D).
M1 and M3 receptors are involved in carbachol-induced increase in H2S production in human 
urothelium and T24 cells. M receptors (M1, M2, M3, M4 and M5) are expressed as mRNA either in human 
urothelium or in T24 cells (Fig. 4A). In order to address the involvement of a specific subtype of M receptor in 
H2S generation, we have used selective M antagonists. Notably, the blockade of M1 or M3 receptor, with telen-
zepine (10 nM) or 4-DAMP (100 nM) respectively, abrogates carbachol-induced increase in H2S production in 
human urothelium (°p < 0.05 and °°p < 0.01 vs carbachol; Fig. 4B). In T24 cells, only the blockade of M1 receptor 
with telenzepine, significantly reduces carbachol-induced increase in H2S production (°°°p < 0.001 vs carbachol; 
Fig. 4C).
Discussion
The urinary bladder expresses all M receptor subtypes that are widely and heterogeneously distributed, in the 
different area of the bladder22. Activation of M receptors on the detrusor muscle triggers the contractile response 
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necessary for urinary bladder voiding. However, M receptors are also involved in relaxing bladder9,10,23. This 
Janus effect (doubled edged effect) implies that different downstream signaling as well as mediators must be 
involved following M receptors activation within the bladder structure. Here, we have addressed the role of H2S 
as possible downstream mediator following activation of M receptors within the urothelium. Indeed, endogenous 
H2S is a signaling molecule which participates in the regulation of various physiological processes in human 
urogenital-tract11,16,17,21,24–26. The choice of the urothelium stems from the finding that CBS is markedly expressed 
in the urothelium as compared to CSE and that its activity is specifically enhanced upon phosphorylation21. 
Indeed, CBS is phosphorylated at Ser227 in a cGMP/PKG-dependent mechanism21. We have shown that the 
human bladder, as also reported by others, contracts to carbachol in vitro and this contractile effect is enhanced 
upon urothelium removal9,10,27,28. In addition, the inhibition of CBS, significantly increased carbachol-induced 
contraction in human bladder strips with intact urothelium while, PAG, a CSE inhibitor, did not significantly 
modify carbachol effect. This data indicates that i) urothelium dynamically contributes to pacing the contractile 
cholinergic stimulation and ii) endogenous production of H2S is involved in bladder tone. This hypothesis is fur-
ther sustained by the finding that carbachol causes a significant concentration-dependent increase in H2S produc-
tion in human urothelium. As it happened in the functional study, the inhibition of CBS blocks carbachol-induced 
H2S production in human tissue. Therefore, H2S is involved as downstream signaling mediator following cholin-
ergic stimulation in urothelium. In order to further address this issue, we used the T24 cell line that mimics 
the human urothelium biochemical profile for what concerns the H2S pathway, as previously demonstrated21. 
T24 cells express all M receptor subtypes and, as expected, carbachol causes a significant enhancement in H2S 
production in T24 cells that is reversed by AOAA. Since AOAA is not selective for CBS29, in order to confirm 
the role hypothesized for CBS-derived H2S, we silenced CBS in T24 cells. In the T24 CBS silenced cells challenge 
with carbachol failed to increase H2S production confirming a key role for CBS-derived H2S. Thus, following 
activation of the M receptors the downstream activation of CBS is necessary in order to trigger H2S produc-
tion. Since PKA is almost absent in human urothelium as well as in T24 cells we have investigated the possible 
involvement of cGMP21. A role for the NO/cGMP in relaxing effect specially in bladder neck and urethra has 
been demonstrated30. Here, the activation of M receptors by carbachol causes an increase in cGMP levels in T24 
cells. In parallel, the western blot analysis confirmed the presence of eNOS in the urothelium. Thus, our results 
suggest a role for NO/cGMP in detrusor muscle dome through urothelium M stimulation. In order to evaluate 
the involvement of the NO/cGMP/PKG pathway following M receptor activation in urothelium we modulated 
eNOS or PKG activity by using the selective inhibitors, L-NIO or KT5823 respectively. Both treatments inhibited 
Figure 1. Carbachol induces contraction in human bladder strips. (A) Carbachol-induced contraction is 
significantly higher in human bladder strips without urothelium compared to strips with intact urothelium 
(*p < 0.05). Data are calculated as dyne/mg of tissue. (B) Delta % of increase in contraction induced by carbachol 
(10 nM–30 μ M) in bladder strips with intact urothelium is not modified by PAG (10 mM), a CSE inhibitor. AOAA 
(1 mM), a CBS inhibitor, significantly increased carbachol induced contraction (* p < 0.05). AOAA effect was 
significantly higher than PAG (°p < 0.05). All data are expressed as mean ± SE of four different experiments.
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carbachol-induced H2S production bringing back to control levels. As expected, the increased cGMP production 
translated into an increased phosphorylation of CBS at Ser227 in T24 cells. Therefore, taken together all these 
findings imply that following M receptor stimulation eNOS/cGMP pathway is activated and cGMP produced in 
turn phosphorylates CBS in a PKG-dependent manner, thereby increasing H2S production. In order to investigate 
which M receptor (M1–M5) was involved in carbachol-induced H2S generation, we used different selective M1 
to M4 receptor inhibitors since there are no available selective M5 receptor inhibitors. In T24 cells only telenze-
pine, an M1 antagonist, reduced H2S production while in human urothelium, the blockade of either M1 or M3 
receptor reversed carbachol-induced increase in H2S production. Thus, although all M receptors are expressed in 
human bladder urothelium, only M1 and M3 appear to be involved in H2S production most likely for the specific 
anatomical localization. Indeed, in human urothelium, M1 receptor is localized on basal cells, M2 on umbrella 
Figure 2. Carbachol increases H2S production in human urothelium and T24 cells. (A,B) Carbachol (0.1, 1 
and 10 μ M) causes a significant increase in H2S generation in human urothelium and in T24 cells, respectively 
(* * p < 0.01 and * * * p < 0.001 vs vehicle). (C,D) AOAA (1 mM), a CBS inhibitor, abolishes the increase in 
H2S production induced by carbachol (1 μ M) in human urothelium (* * * p < 0.001 vs vehicle, °°°p < 0.001 vs 
carbachol) and in T24 cells (* * * p < 0.001 vs vehicle, °°p < 0.01 vs carbachol). (E) Western blot analysis for 
CBS in T24 cells or T24Δ CBS cells, using β -actin as a protein loading control. (F) H2S production in T24Δ 
CBS is not modified by carbachol (0.1, 1 and 10 μ M) compared to vehicle. Data are calculated as nanomoles per 
milligram of protein per min and expressed as mean ± SE of four different experiments.
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Figure 3. Carbachol-phosphorylates CBS involving NO/cGMP/PKG signaling in T24 cells. (A) Western blot 
for eNOS in T24 cells or human urothelium (upper). Carbachol stimulation (0.1, 1 and 10 μ M) increases cGMP 
production compared with vehicle (* p < 0.05). (B) L-NIO (1 μ M) or KT5823 (10 μ M), eNOS or PKG inhibitors 
respectively, reduces carbachol-induced increase in H2S production (°°°p < 0.001 vs carbachol). (C) Western blot 
analysis for CBS, pCBS (ser227) in T24 cells stimulated with vehicle, carbachol (0.1, 1 and 10 μ M) or in presence 
of KT5823 (10 μ M), a PKG inhibitor. β -actin was used as a protein loading control. (D) Carbachol (0.1, 1 and 
10 μM) significantly increases CBS phosphorylation compared with vehicle (* * p < 0.01 and ***p < 0.001 vs 
vehicle). KT5823 (10 μ M), a PKG inhibitor, inhibits CBS phosphorylation induced by carbachol (°°p < 0.01; 
°°°p < 0.001 vs carbachol). Western blot analysis data are quantified by densitometric evaluation and expressed 
as mean ± SE of four different experiments. H2S production data are calculated as nanomoles per milligram of 
protein per min and expressed as mean ± SE of four different experiments.
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Figure 4. Muscarinic receptors involvement in carbachol induced increase in H2S production. (A) Semi 
quantitative RT-PCR for muscarinic receptors M1, M2, M3, M4, M5 in T24 cells and human urothelim 
respectively. (B) Telenzepine (10 nM) or 4DAMP (100 nM), M1 and M3 antagonists respectively, significantly 
reduces carbachol-induced increase in H2S production in human urothelium (* * * p < 0.001 vs vehicle, °p < 0.05 
and °°p < 0.01 vs carbachol). (C) The blockage of M1 receptor (telenzepine 10 nM) markedly reduces H2S 
generation compared with carbachol in T24 cells (* * * p < 0.001 vs vehicle, °°°p < 0.001 vs carbachol). H2S 
production data are calculated as nanomoles per milligram of protein per min and expressed as mean ± SE of 
four different experiments.
www.nature.com/scientificreports/
7Scientific RepoRts | 6:31491 | DOI: 10.1038/srep31491
cells, M3 and M4 homogenously and M5 with a decreasing gradient from luminal to basal cells31. The M1 recep-
tor localization on basal cells that are anatomically strictly attached to detrusor muscle, suggests that H2S, once 
generated, can easily diffuse to the detrusor muscle contributing to its relaxation. Besides, our results suggest H2S 
as a possible candidate for UDRF. Indeed, previous studies demonstrated that M1 and M3 receptors stimulation 
induce the release of UDRF in rat bladder23. The identification of H2S as an UDRF in human bladder implies a 
role for this pathway in bladder tone and possibly in micturition. The urothelium impermeability is necessary 
for the normal bladder functioning, but at the same time represents limitations regarding the uptake of drugs. 
Therefore, the development of releasing-H2S drugs may represent a feasible therapeutic approach to bladder dis-
orders. However our data strongly imply that the cholinergic stimulation triggers the detrusor muscle contraction 
but at the same time triggers the release of H2S by the urothelium. Therefore, it is feasible to hypothesize that in 
healthy condition a balance between these two signals e.g. contracting and relaxing effect contributes to bladder 
homeostasis. Conversely, in pathological condition, such as in overactive bladder, the detrusor contracting effect 
may predominate while in hyporeactive bladder the urothelium relaxing effect may prevail. To date, the knowl-
edge of human bladder physiology is still unclear but our findings may open new frontiers in this field and may 
contextually offer the basis for novel pharmacological approaches in the management of bladder disorders.
Methods
Human tissue. Full thickness bladder dome samples were obtained from 15 patients, aged 61–73 years, 
affected with benign prostatic hyperplasia that underwent open prostatectomy. All patients presented urody-
namic obstruction and large prostate volume (> 80 ml). Patients were excluded if they presented bladder stones, 
urinary infections, detrusor areflexia and/or a history of urothelial cancer. The research has been carried out in 
accordance with the Declaration of Helsinki (2013) of the World Medical Association. The Ethical Committee of 
the Institution (School of Medicine and Surgery, University of Naples Federico II, via Pansini, 5; 80131, Naples, 
Italy) in which the work was performed has approved it. The subjects have given written informed consent to 
the work.
Human bladder strips. The bladder sections (detrusor muscle plus urothelium), obtained from patients 
were excised from each donor sample, and longitudinal strips were isolated. Strips were suspended in organ 
chambers filled with Krebs buffer (37 °C, 95% oxygen and 5% carbon dioxide) with the following composition: 
sodium chloride,115.3 mM; potassium chloride, 4.9 mM; calcium chloride, 1.46 mM; magnesium sulfate, 1.2 mM; 
potassium dihydrogen phosphate, 1.2 mM; sodium bicarbonate, 25.0 mM; and glucose, 11.1 mM (Carlo Erba, 
Milan, Italy). The strips were connected to isometric force transducers (model 7002, Ugo Basile, Comerio, Italy) 
and a tension of 0.5 g was applied. The tension changes were registered and monitored by a computerized system 
(DataCapsule, Ugo Basile, Comerio, Italy). The tissues were equilibrated (60 min) and standardized by repeated 
contractions with carbachol (1 μ M; Sigma, Milan, Italy). The strips with or without urothelium were challenged 
with carbachol (1 μ M). The contraction was calculated as dyne/mg tissue and expressed as mean ± SE. The results 
were analyzed using Student’s t-test. In another setting of experiments, a concentration-response curve of car-
bachol (10 nM up to 30 μ M) was performed in presence of urothelium and thereafter the curve was repeated 
in presence of vehicle, PAG, a CSE inhibitor (10 mM, Sigma, Milan, Italy), or AOAA, a CBS inhibitor (1 mM; 
Sigma, Milan, Italy) after 20 min of incubation. Data were calculated as delta percentage of increase in contraction 
between the two repeated concentration-response curve of carbachol. Data were expressed as mean ± SE and 
analyzed by using one way ANOVA. p < 0.05 was considered significant.
Cell culture. The urothelial T24 cell line (American Type Culture Collection, ATCC, HTB-4) was cultured as 
previously described32.
CBS silencing. To stably silence CBS, T24 cells were seeded the day before transfection in a 60 mm plate. 
Cells were transfected 24 hours later, with 2 μ g of a CBS short hairpin (sh)RNA expressing vector purchased from 
Santa Cruz Biotechnology (Santa Cruz Biotechnology, Santa Cruz, CA, USA). CBS silenced cells (T24Δ CBS) 
were selected as previously described33.
The CBS depletion was evaluated by western blot using a rabbit polyclonal anti-CBS (Santa Cruz 
Biotechnology, DBA, Milan, Italy). The cell clone with lowest expression level was selected and used for further 
experiments. A short hairpin non-silencing construct was used as control.
RT-PCR analyses. The mRNA level of M receptors (M1–M5) in urothelial tissue and in T24 cells was deter-
mined by using RT-semi-quantitative PCR (RT-PCR) method34. Total RNA was extracted from samples by using 
an ultrapure TRizol reagent (GibcoBRL) as directed by the manufacturer. RNA (2 μ g) was reverse-transcribed to 
cDNA through SuperScript III First-Strand Synthesis system (iScriptTM cDNA Syntesis Kit, Biorad, Italy) accord-
ing to the manufacturer’s protocol in the presence of random hexamers (5 μ M), 20 U of RNasin (Promega), dNTP 
(1mM) for 1 h at 42 °C. RT-PCR was performed on 1 ml of the reverse transcription reaction mixture in a final 
volume of 50 ml with 2 U of Taq DNA Polymerase (VWR, Italy) and 1 mM of appropriate primers (Table 1). 
To obtain a linear amplification curves, the cDNA mixtures were subjected to denaturation at 95 °C for 1 min, 
annealing at 58 °C for 1 min for M2, M3 and β -actin and at 60 °C for M1, M4 and M5 and extension at 72 °C for 
15 min.
Human tissues and T24 cells treatments. In order to measure H2S production, human urothelial sam-
ples, T24 cells or T24Δ CBS were incubated with carbachol (Sigma-Aldrich, Milan, Italy) for 5 min at different 
concentrations (0.1, 1 and 10 μ M). On the basis of these results, 1 μ M was chosen as the optimal concentration. 
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Thus, in another setting of experiments, human urothelial samples or T24 cells were pre-treated with AOAA 
(1 mM, for 20 min), a CBS inhibitor, and then challenged with carbachol (1 μ M, for 5 min). The carbachol-induced 
effect was also evaluated in presence of telenzepine (10 nM, M1 antagonist), AFDX (100 nM, M2 antagonist), 
4DAMP (100 nM, M3 antagonist) or PD102809 (100 nM, M4 antagonist). Finally, in order to investigate the 
underlying mechanism, T24 cells were pretreated with L-NIO, an endothelial nitric oxide synthase (eNOS) inhib-
itor (1 μ M, Tocris UK) or KT5823, a PKG inhibitor (10 μ M, Tocris UK) and thereafter stimulated with carbachol 
(1 μ M, for 5 min).
H2S determination. H2S production was evaluated as reported by d’Emmanuele di Villa Bianca and 
coworkers35. Human urothelial samples or T24 cells were homogenized with lysis buffer containing potassium 
phosphate buffer (100 mM, pH 7.4), sodium orthovanadate (10 mM) and proteases inhibitors. Homogenates were 
added for 40 min in a reaction mixture (total volume 500 μ l) containing piridoxal-5′ -phosphate (2 mM, 20 μ l) and 
saline (20 μ l) or L-cysteine (10 mM, 20 μ l, Sigma-Aldrich, Milan, Italy) to measure enzyme activity i.e. H2S gen-
eration. The reaction was performed in parafilmed Eppendorf tubes and initiated by transferring tubes from ice 
to a water bath at 37 °C and carried out for 40 min. After incubation, zinc acetate (1%, 250 μ l, Sigma-Aldrich) and 
trichloroacetic acid (10%, 250 μ l) were added. Subsequently, N,N-dimethyl-p-phenylendiamine sulfate (DPD, 
20 mM, Sigma-Aldrich) in HCl (7.2 M) and iron chloride (FeCl3, 30 mM, Sigma-Aldrich) in HCl (1.2 M) were 
added and optical absorbance of the solutions was measured after 20 min at a wavelength of 667 nm. All samples 
were assayed in duplicate and H2S concentration was calculated against a calibration curve of NaHS (3.9–250 μM, 
Sigma-Aldrich). Results were calculated as nmol/mg protein/min and expressed as mean ± SE. Data were ana-
lyzed by using one way ANOVA following by Bonferroni as post test. p < 0.05 was considered significant.
cGMP measurement in T24 cells. In order to measure the cGMP content, T24 cells were treated with 
carbachol (0.1, 1 and10 μ M) for 5 min and then immediately frozen. T24 cells were treated with 15 μ l of 3.3 M 
HCl and then centrifuged (600× g for 10 min); the cGMP levels were measured in supernatants as previously 
reported36,37 by using an immune assay kit (Cayman; Vinci Biochem, Vinci, Italy). Results were calculated as 
pmol/ml and expressed as mean ± SE. Data were analyzed by using one way ANOVA following by Bonferroni as 
post test. p < 0.05 was considered significant.
Western blot analysis in T24 cells. T24 cells treated with carbachol (0.1, 1 and 10 μ M, for 5 min) were ana-
lyzed by western blotting in presence or in absence of KT5823 (10 μ M), a PKG inhibitor (Tocris, UK). Protein samples 
(30 μ g) were resolved by 12% SDS-PAGE and analyzed as previously described38,39.The membranes were incubated 
with rabbit polyclonal anti-CBS, (1:1000 Santa Cruz Biotechnology, Heidelberg, Germany), and anti-pCBSSer227 
(1:400, PRIMM srl, Milano, Italy)21. In another setting of experiments T24 cells or human urothelium were blotted 
for anti-eNOS (1:1000, BD Transduction, CA, USA). The target protein band intensity was normalized over the 
intensity of the housekeeping β -actin (1:5000, Sigma-Aldrich, Milan, Italy). Data were expressed as mean  ±  SE. 
Results were analyzed by ANOVA following by Bonferroni as post test. p  <  0.05 was considered significant.
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